+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 6Years - 17Years
All Genders
ID05332067

Study of Omalizumab Treatment to Prevent Asthma Exacerbations in Children and Teens Aged 6-17 During Fall Viral Infections

Led by Children's National Research Institute · Updated on 2025-07-14

300

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effect of a single dose of the drug omalizumab compared to a placebo in children and adolescents aged 6 to 17 years who have persistent asthma and are prone to frequent asthma flare-ups. The study targets urban, atopic youth during the fall season to see if early treatment at the start of viral upper respiratory infections URIs can influence immune response. The trial is a randomized, controlled pilot study conducted over three years with three annual groups of participants. Participants will receive either one dose of omalizumab or a placebo injection at the onset of URI symptoms such as runny nose, nasal congestion, or sneezing during the fall season after returning to school. Before this, they will have a 2- to 6-month run-in period to stabilize their asthma and medication under routine care visits every 1 to 2 months. The omalizumab dose is individualized based on weight and total IgE levels, and the placebo matches the drug in appearance and administration. Throughout the study, participants will be closely monitored for changes in nasal interferon-alpha levels within 3 to 6 days after treatment, which is the primary outcome. Additional measures include nasal type 2 cytokines and asthma exacerbations following treatment. Researchers will conduct nasal fluid samples, rapid nasal swab tests for COVID-19, and regular asthma control assessments. The involvement lasts through the fall season with follow-up visits to evaluate immune response and asthma symptoms after treatment onset.

CONDITIONS

Brief Title

Omalizumab Before Onset of Exacerbations

Research Team

W

William Sheehan, MD

A

Alicia Mathis

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here